|
MIOS expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.11022302462516E-16 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
2.13410400462521E-11 |
| Normal-vs-Stage3 |
1.62503344114384E-12 |
| Normal-vs-Stage4 |
1.62458935193399E-12 |
| Stage1-vs-Stage2 |
4.744800E-01 |
| Stage1-vs-Stage3 |
5.877200E-01 |
| Stage1-vs-Stage4 |
7.876200E-02 |
| Stage2-vs-Stage3 |
7.862800E-01 |
| Stage2-vs-Stage4 |
4.180200E-01 |
| Stage3-vs-Stage4 |
2.341000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
4.65989469233818E-11 |
| Normal-vs-Asian |
1.62458935193399E-12 |
| Caucasian-vs-AfricanAmerican |
7.018200E-01 |
| Caucasian-vs-Asian |
6.719600E-02 |
| AfricanAmerican-vs-Asian |
3.512400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
8.640400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
<1E-12 |
| Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(61-80Yrs) |
1.68398628375144E-12 |
| Normal-vs-Age(81-100Yrs) |
2.11100000035991E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.299400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.892800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.147000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.046000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.995000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.134200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.826200E-02 |
| Classical-VS-Follicular |
1.623230E-01 |
| Classical-VS-Other |
6.422400E-01 |
| Classical-VS-Normal |
1.11022302462516E-16 |
| Tall-VS-Follicular |
5.659800E-01 |
| Tall-VS-Other |
6.927200E-01 |
| Tall-VS-Normal |
1.81099579776856E-12 |
| Follicular-VS-Other |
9.454600E-01 |
| Follicular-VS-Normal |
7.99360577730113E-15 |
| Other-VS-Normal |
4.49570000000676E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62436730732907E-12 |
| Normal-vs-N1 |
1.62769797640294E-12 |
| N0-vs-N1 |
2.055400E-01 |
|
|
